Ascletis Pharma Inc.
ASCLF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$87,951 | -$170,618 | -$130,318 | -$128,156 |
| Dep. & Amort. | $9,440 | $10,432 | $10,321 | $9,646 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3,836 | $1,337 | $1,666 | -$597 |
| Change in WC | $0 | $15,993 | $0 | $53,277 |
| Other Non-Cash | -$98,315 | $4,692 | -$85,084 | -$10,373 |
| Operating Cash Flow | -$172,990 | -$138,164 | -$203,415 | -$76,203 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$2,095 | $0 | -$4,364 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $904,605 | $719,368 | $261,633 | $12,524 |
| Investing Cash Flow | $904,605 | $717,273 | $261,633 | $8,160 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$12,800 | -$98,531 | $0 | -$68,918 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,685 | $40,478 | -$45,455 | -$1,180 |
| Financing Cash Flow | -$14,485 | -$58,053 | -$45,455 | -$70,098 |
| Forex Effect | -$1,116 | $276 | $114 | -$1,436 |
| Net Chg. in Cash | $0 | $0 | $6,438 | -$69,789 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $0 | $6,438 | -$69,789 |
| End Cash | $0 | $0 | $6,438 | -$69,789 |
| Free Cash Flow | -$172,990 | -$140,259 | -$203,415 | -$80,567 |